Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Personalized Treatment for Lacrimal Sac Adenoid Cystic Carcinoma - Case Report and Literature Review.

Bowen RC, Ko HC, Avey GD, Hartig GK, Hu R, Harari PM, Lucarelli MJ.

Pract Radiat Oncol. 2019 Feb 4. pii: S1879-8500(19)30045-1. doi: 10.1016/j.prro.2019.01.011. [Epub ahead of print] No abstract available.

PMID:
30731273
2.

A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy.

Rosenberg SA, Henke LE, Shaverdian N, Mittauer K, Wojcieszynski AP, Hullett CR, Kamrava M, Lamb J, Cao M, Green OL, Kashani R, Paliwal B, Bayouth J, Harari PM, Olsen JR, Lee P, Parikh PJ, Bassetti M.

Adv Radiat Oncol. 2018 Aug 23;4(1):142-149. doi: 10.1016/j.adro.2018.08.005. eCollection 2019 Jan-Mar.

3.

Is HPV-Associated Oropharyngeal Cancer Becoming More Common in Older Patients?

Thompson JD, Harari PM, Hartig GK.

Laryngoscope Investig Otolaryngol. 2018 Oct 15;3(6):446-449. doi: 10.1002/lio2.181. eCollection 2018 Dec.

4.

Randomized phase II/III confirmatory treatment selection design with a change of survival end points: Statistical design of Radiation Therapy Oncology Group 1216.

Zhang QE, Wu Q, Harari PM, Rosenthal DI.

Head Neck. 2019 Jan;41(1):37-45. doi: 10.1002/hed.25359. Epub 2018 Dec 14.

PMID:
30549358
5.

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT.

Lancet. 2019 Jan 5;393(10166):40-50. doi: 10.1016/S0140-6736(18)32779-X. Epub 2018 Nov 15.

PMID:
30449625
6.

HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients.

Burr AR, Harari PM, Ko HC, Chen S, Yu M, Baschnagel AM, Kimple RJ, Witek ME.

Otorhinolaryngol Head Neck Surg. 2018;3(1). doi: 10.15761/OHNS.1000160. Epub 2018 Feb 24.

7.

Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog.

Elsaid MY, Shahi A, Wang AR, Baiu DC, Li C, Werner LR, Singhal S, Hall LT, Weichert JP, Armstrong EA, Bednarz BP, Harari PM, Iyer G, Otto M.

Mol Cancer Ther. 2018 Nov;17(11):2320-2328. doi: 10.1158/1535-7163.MCT-17-0897. Epub 2018 Aug 14.

PMID:
30108133
8.

MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents.

McDaniel NK, Cummings CT, Iida M, Hülse J, Pearson HE, Vasileiadi E, Parker RE, Orbuch RA, Ondracek OJ, Welke NB, Kang GH, Davies KD, Wang X, Frye SV, Earp HS, Harari PM, Kimple RJ, DeRyckere D, Graham DK, Wheeler DL.

Mol Cancer Ther. 2018 Nov;17(11):2297-2308. doi: 10.1158/1535-7163.MCT-17-1239. Epub 2018 Aug 9.

PMID:
30093568
9.

Results From 10 Years of a Free Oral Cancer Screening Clinic at a Major Academic Health Center.

Blitzer GC, Rosenberg SA, Anderson BM, McCulloch TM, Wieland AM, Hartig GK, Bruce JY, Witek ME, Kimple RJ, Harari PM.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):146-148. doi: 10.1016/j.ijrobp.2018.05.007. Epub 2018 Jul 3. No abstract available.

PMID:
29980415
10.

A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic Malignancies.

Mittauer K, Paliwal B, Hill P, Bayouth JE, Geurts MW, Baschnagel AM, Bradley KA, Harari PM, Rosenberg S, Brower JV, Wojcieszynski AP, Hullett C, Bayliss RA, Labby ZE, Bassetti MF.

Cureus. 2018 Apr 4;10(4):e2422. doi: 10.7759/cureus.2422.

11.

Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites.

Morris ZS, Guy EI, Werner LR, Carlson PM, Heinze CM, Kler JS, Busche SM, Jaquish AA, Sriramaneni RN, Carmichael LL, Loibner H, Gillies SD, Korman AJ, Erbe AK, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM.

Cancer Immunol Res. 2018 Jul;6(7):825-834. doi: 10.1158/2326-6066.CIR-17-0353. Epub 2018 May 10.

PMID:
29748391
12.

Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.

Bristow RG, Alexander B, Baumann M, Bratman SV, Brown JM, Camphausen K, Choyke P, Citrin D, Contessa JN, Dicker A, Kirsch DG, Krause M, Le QT, Milosevic M, Morris ZS, Sarkaria JN, Sondel PM, Tran PT, Wilson GD, Willers H, Wong RKS, Harari PM.

Lancet Oncol. 2018 May;19(5):e240-e251. doi: 10.1016/S1470-2045(18)30096-2. Review.

PMID:
29726389
13.

Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx-Reply.

Witek ME, Hartig GK, Harari PM.

JAMA Otolaryngol Head Neck Surg. 2018 Jun 1;144(6):543. doi: 10.1001/jamaoto.2018.0083. No abstract available.

PMID:
29621382
14.

Impact of HPV Status on the Prognostic Potential of the AJCC Staging System for Larynx Cancer.

Davidson SM, Ko HC, Harari PM, Wieland AM, Chen S, Baschnagel AM, Kimple RJ, Witek ME.

Otolaryngol Head Neck Surg. 2018 Sep;159(3):456-465. doi: 10.1177/0194599818766035. Epub 2018 Apr 3.

PMID:
29611770
15.

When Disaster Strikes: Mitigating the Adverse Impact on Head and Neck Cancer Patients.

Yom SS, Harari PM.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):838-840. doi: 10.1016/j.ijrobp.2017.12.008. No abstract available.

PMID:
29485057
16.

Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx.

Ko HC, Harari PM, Chen S, Wieland AM, Yu M, Baschnagel AM, Kimple RJ, Witek ME.

JAMA Otolaryngol Head Neck Surg. 2017 Nov 1;143(11):1126-1133. doi: 10.1001/jamaoto.2017.1756.

17.

Lymph Node Yield in Therapeutic Neck Dissection: Impact of Dissection Levels and Prior Radiotherapy.

Lippert D, Dang P, Cannon D, Harari PM, McCulloch TM, Hoffman MR, Hartig GK.

Ann Otol Rhinol Laryngol. 2017 Nov;126(11):762-767. doi: 10.1177/0003489417730839. Epub 2017 Sep 26.

PMID:
28948832
18.

Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma.

Werner LR, Kler JS, Gressett MM, Riegert M, Werner LK, Heinze CM, Kern JG, Abbariki M, Erbe AK, Patel RB, Sriramaneni RN, Harari PM, Morris ZS.

Radiother Oncol. 2017 Sep;124(3):418-426. doi: 10.1016/j.radonc.2017.08.016. Epub 2017 Sep 8.

19.

Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.

Ko HC, Harari PM, Sacotte RM, Chen S, Wieland AM, Yu M, Baschnagel AM, Bruce JY, Kimple RJ, Witek ME.

J Cancer Res Clin Oncol. 2017 Nov;143(11):2341-2350. doi: 10.1007/s00432-017-2481-8. Epub 2017 Jul 27.

PMID:
28752235
20.

Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.

Ko HC, Chen S, Wieland AM, Yu M, Baschnagel AM, Hartig GK, Harari PM, Witek ME.

Head Neck. 2017 Nov;39(11):2159-2170. doi: 10.1002/hed.24881. Epub 2017 Jul 24.

21.

Why So Challenging to Personalize Radiation Dose?

Harari PM.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1012-1013. doi: 10.1016/j.ijrobp.2017.03.021. Epub 2017 Jul 10. No abstract available.

PMID:
28721882
22.

Radiosensitization of Adenoid Cystic Carcinoma with MDM2 Inhibition.

Prabakaran PJ, Javaid AM, Swick AD, Werner LR, Nickel KP, Sampene E, Hu R, Ong IM, Bruce JY, Hartig GK, Wieland AM, Canon J, Harari PM, Kimple RJ.

Clin Cancer Res. 2017 Oct 15;23(20):6044-6053. doi: 10.1158/1078-0432.CCR-17-0969. Epub 2017 Jun 28.

23.

Small cell carcinoma of the head and neck: An analysis of the National Cancer Database.

Pointer KB, Ko HC, Brower JV, Witek ME, Kimple RJ, Lloyd RV, Harari PM, Baschnagel AM.

Oral Oncol. 2017 Jun;69:92-98. doi: 10.1016/j.oraloncology.2017.04.009. Epub 2017 Apr 25.

24.

Obituary and Tribute to John "Jack" Francis Fowler, PhD, DSc (1925-2016).

Harari PM, Ritter MA, van der Kogel AJ.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):886-888. doi: 10.1016/j.ijrobp.2017.01.015. Epub 2017 Jan 10. No abstract available.

PMID:
28333004
25.

Chondroradionecrosis of the larynx: 24-year University of Wisconsin experience.

Gessert TG, Britt CJ, Maas AMW, Wieland AM, Harari PM, Hartig GK.

Head Neck. 2017 Jun;39(6):1189-1194. doi: 10.1002/hed.24749. Epub 2017 Mar 11.

PMID:
28295829
26.

Identification of stable housekeeping genes in response to ionizing radiation in cancer research.

Iyer G, Wang AR, Brennan SR, Bourgeois S, Armstrong E, Shah P, Harari PM.

Sci Rep. 2017 Mar 6;7:43763. doi: 10.1038/srep43763.

27.

Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.

Wojcieszynski AP, Hill PM, Rosenberg SA, Hullett CR, Labby ZE, Paliwal B, Geurts MW, Bayliss RA, Bayouth JE, Harari PM, Bassetti MF, Baschnagel AM.

Technol Cancer Res Treat. 2017 Jun;16(3):366-372. doi: 10.1177/1533034617691407. Epub 2017 Feb 7.

28.

Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease.

Witek ME, Wieland AM, Chen S, Kennedy TA, Hullett CR, Liang E, Hartig GK, Kimple RJ, Harari PM.

Cancers Head Neck. 2017;2. pii: 8. doi: 10.1186/s41199-017-0027-z. Epub 2017 Nov 14.

29.
30.

Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012.

Brower JV, Chen S, Bassetti MF, Yu M, Harari PM, Ritter MA, Baschnagel AM.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):985-993. doi: 10.1016/j.ijrobp.2016.08.016. Epub 2016 Aug 23.

PMID:
27869098
31.

Randomized Phase II Study of Duligotuzumab (MEHD7945A) vs. Cetuximab in Squamous Cell Carcinoma of the Head and Neck (MEHGAN Study).

Fayette J, Wirth L, Oprean C, Udrea A, Jimeno A, Rischin D, Nutting C, Harari PM, Csoszi T, Cernea D, O'Brien P, Hanley WD, Kapp AV, Anderson M, Penuel E, McCall B, Pirzkall A, Vermorken JB.

Front Oncol. 2016 Oct 31;6:232. eCollection 2016.

33.

Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database.

Brower JV, Amini A, Chen S, Hullett CR, Kimple RJ, Wojcieszynski AP, Bassetti M, Witek ME, Yu M, Harari PM, Baschnagel AM.

Ann Oncol. 2016 Oct;27(10):1887-94. doi: 10.1093/annonc/mdw276. Epub 2016 Aug 8.

PMID:
27502703
34.

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).

Divi V, Harris J, Harari PM, Cooper JS, McHugh J, Bell D, Sturgis EM, Cmelak AJ, Suntharalingam M, Raben D, Kim H, Spencer SA, Laramore GE, Trotti A, Foote RL, Schultz C, Thorstad WL, Zhang QE, Le QT, Holsinger FC.

Cancer. 2016 Nov 15;122(22):3464-3471. doi: 10.1002/cncr.30204. Epub 2016 Jul 15.

35.

Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial.

Bonner JA, Giralt J, Harari PM, Baselga J, Spencer S, Bell D, Raben D, Liu J, Schulten J, Ang KK, Rosenthal DI.

Eur J Cancer. 2016 Sep;64:1-11. doi: 10.1016/j.ejca.2016.05.008. Epub 2016 Jun 17.

36.

Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology.

Huang S, Peter Rodemann H, Harari PM.

Recent Results Cancer Res. 2016;198:45-87. doi: 10.1007/978-3-662-49651-0_3. Review.

PMID:
27318681
37.

Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.

Bar-Ad V, Zhang QE, Harari PM, Axelrod R, Rosenthal DI, Trotti A, Jones CU, Garden AS, Song G, Foote RL, Raben D, Shenouda G, Spencer SA, Harris J, Le QT.

Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1346-1354. doi: 10.1016/j.ijrobp.2016.03.011. Epub 2016 Mar 26.

38.

Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.

Morris ZS, Saha S, Magnuson WJ, Morris BA, Borkenhagen JF, Ching A, Hirose G, McMurry V, Francis DM, Harari PM, Chappell R, Tsuji S, Ritter MA.

Cancer. 2016 Aug 15;122(16):2487-95. doi: 10.1002/cncr.30079. Epub 2016 May 20.

39.

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments.

Morris ZS, Guy EI, Francis DM, Gressett MM, Werner LR, Carmichael LL, Yang RK, Armstrong EA, Huang S, Navid F, Gillies SD, Korman A, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM.

Cancer Res. 2016 Jul 1;76(13):3929-41. doi: 10.1158/0008-5472.CAN-15-2644. Epub 2016 May 6.

40.

Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining: A Validation by Clinical Outcomes.

Barasch S, Mohindra P, Hennrick K, Hartig GK, Harari PM, Yang DT.

Am J Surg Pathol. 2016 Sep;40(9):1261-9. doi: 10.1097/PAS.0000000000000666.

41.
42.

Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liver.

Wojcieszynski AP, Rosenberg SA, Brower JV, Hullett CR, Geurts MW, Labby ZE, Hill PM, Bayliss RA, Paliwal B, Bayouth JE, Harari PM, Bassetti MF.

Radiother Oncol. 2016 Feb;118(2):416-8. doi: 10.1016/j.radonc.2015.10.024. Epub 2015 Nov 25.

PMID:
26627702
43.

Simulation study of high-dose-rate brachytherapy for early glottic cancer.

Hoffman MR, McCulloch TM, Mohindra P, Das R, Geurts M, Harari PM.

Brachytherapy. 2016 Jan-Feb;15(1):94-101. doi: 10.1016/j.brachy.2015.10.007. Epub 2015 Nov 21.

PMID:
26614234
44.

Pan-HER Inhibitor Augments Radiation Response in Human Lung and Head and Neck Cancer Models.

Francis DM, Huang S, Armstrong EA, Werner LR, Hullett C, Li C, Morris ZS, Swick AD, Kragh M, Lantto J, Kimple RJ, Harari PM.

Clin Cancer Res. 2016 Feb 1;22(3):633-43. doi: 10.1158/1078-0432.CCR-15-1664. Epub 2015 Sep 29.

45.

Small Molecule Inhibition of MDM2-p53 Interaction Augments Radiation Response in Human Tumors.

Werner LR, Huang S, Francis DM, Armstrong EA, Ma F, Li C, Iyer G, Canon J, Harari PM.

Mol Cancer Ther. 2015 Sep;14(9):1994-2003. doi: 10.1158/1535-7163.MCT-14-1056-T. Epub 2015 Jul 10.

46.

Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers.

Li C, Huang S, Armstrong EA, Francis DM, Werner LR, Sliwkowski MX, van der Kogel A, Harari PM.

Mol Cancer Ther. 2015 Sep;14(9):2049-59. doi: 10.1158/1535-7163.MCT-15-0155. Epub 2015 Jul 3.

47.

Quantitative evaluation of image segmentation incorporating medical consideration functions.

Kim H, Monroe JI, Lo S, Yao M, Harari PM, Machtay M, Sohn JW.

Med Phys. 2015 Jun;42(6):3013-23. doi: 10.1118/1.4921067.

PMID:
26127054
48.

Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems.

Morris ZS, Weichert JP, Saker J, Armstrong EA, Besemer A, Bednarz B, Kimple RJ, Harari PM.

Radiother Oncol. 2015 Sep;116(3):504-9. doi: 10.1016/j.radonc.2015.06.015. Epub 2015 Jun 26.

49.

The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy.

Kimple RJ, Harari PM.

Ann Transl Med. 2015 May;3(Suppl 1):S14. doi: 10.3978/j.issn.2305-5839.2015.01.37. No abstract available.

50.

Incidental Parotid Neoplasms: Pathology and Prevalence.

Britt CJ, Stein AP, Patel PN, Harari PM, Hartig GK.

Otolaryngol Head Neck Surg. 2015 Oct;153(4):566-8. doi: 10.1177/0194599815586764. Epub 2015 May 27.

PMID:
26019135

Supplemental Content

Loading ...
Support Center